Cargando…

Functional and structural alterations as diagnostic imaging markers for depression in de novo Parkinson’s disease

BACKGROUND: Depression in Parkinson’s disease (PD) is identified and diagnosed with behavioral observations and neuropsychological measurements. Due to the large overlaps of depression and PD symptoms in clinical manifestations, it is challenging for neurologists to distinguish and diagnose depressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hui, Xu, Jianxia, Yu, Miao, Zhou, Gaiyan, Ren, Jingru, Wang, Yajie, Zheng, Huifen, Sun, Yu, Wu, Jun, Liu, Weiguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992430/ https://www.ncbi.nlm.nih.gov/pubmed/36908791 http://dx.doi.org/10.3389/fnins.2023.1101623

Ejemplares similares

Altered Dynamic Functional Connectivity in de novo Parkinson’s Disease Patients With Depression
por: Xu, Jianxia, et al.
Publicado: (2022)

Altered Neural Network Connectivity Predicts Depression in de novo Parkinson’s Disease
por: Xu, Jianxia, et al.
Publicado: (2022)

Association of GBA genotype with motor and cognitive decline in Chinese Parkinson’s disease patients
por: Ren, Jingru, et al.
Publicado: (2023)

Aberrant inter-network functional connectivity in drug-naive Parkinson’s disease patients with tremor dominant and postural instability and gait difficulty
por: Wang, Qi, et al.
Publicado: (2023)

Subjective Cognitive Complaints in Newly-Diagnosed Parkinson’s Disease With and Without Mild Cognitive Impairment
por: Pan, Chenxi, et al.
Publicado: (2021)

Altered functional connectivity of the primary motor cortex in tremor dominant and postural instability gait difficulty subtypes of early drug-naive Parkinson’s disease patients
por: Wang, Qi, et al.
Publicado: (2023)

Plasma α‐synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson’s disease
por: Ren, Jingru, et al.
Publicado: (2022)

Serum miR-214 Serves as a Biomarker for Prodromal Parkinson’s Disease
por: Li, Lanting, et al.
Publicado: (2021)

Consistency and Stability of Motor Subtype Classifications in Patients With de novo Parkinson’s Disease
por: Ren, Jingru, et al.
Publicado: (2021)

Zishen pingchan granules combined with pramipexole in the improvement of depressive symptoms in Parkinson's disease: a prospective, multicenter, randomized, double-blind, controlled clinical study
por: Ning, Houxu, et al.
Publicado: (2022)

Prevalence and affective correlates of subjective cognitive decline in patients with de novo Parkinson's disease
por: Yang, Ning, et al.
Publicado: (2022)

Comparison of Three Motor Subtype Classifications in de novo Parkinson's Disease Patients
por: Ren, Jingru, et al.
Publicado: (2020)

Oculomotor impairments in de novo Parkinson’s disease
por: Zhou, Meng-Xi, et al.
Publicado: (2022)

Genetic Analysis of Patients With Early-Onset Parkinson’s Disease in Eastern China
por: Hua, Ping, et al.
Publicado: (2022)

Network structure of brain atrophy in de novo Parkinson's disease
por: Zeighami, Yashar, et al.
Publicado: (2015)

Progressive Decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging Data
por: Taylor, Kirsten I., et al.
Publicado: (2018)

Altered Spontaneous Neural Activity and Functional Connectivity in Parkinson’s Disease With Subthalamic Microlesion
por: Luo, Bei, et al.
Publicado: (2021)

Alterations of Interhemispheric Functional Connectivity in Parkinson’s Disease With Depression: A Resting-State Functional MRI Study
por: Liao, Haiyan, et al.
Publicado: (2020)

Alterations in Degree Centrality and Functional Connectivity in Parkinson’s Disease Patients With Freezing of Gait: A Resting-State Functional Magnetic Resonance Imaging Study
por: Guo, MiaoRan, et al.
Publicado: (2020)

Altered Brain Activity in Depression of Parkinson’s Disease: A Meta-Analysis and Validation Study
por: Su, Dongning, et al.
Publicado: (2022)

Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson’s disease with freezing of gait
por: Wang, Shangpei, et al.
Publicado: (2023)

Parkinson’s Disease With Depression: The Correlations Between Neuroinflammatory Factors and Neurotransmitters in Cerebrospinal Fluid
por: Lian, Teng-hong, et al.
Publicado: (2020)

Cortical gyrification pattern of depression in Parkinson’s disease: a neuroimaging marker for disease severity?
por: Shen, Qin, et al.
Publicado: (2023)

Identification of Diagnostic Markers for Major Depressive Disorder Using Machine Learning Methods
por: Zhao, Shu, et al.
Publicado: (2021)

Prevalence and genotype–phenotype correlations of GBA‐related Parkinson disease in a large Chinese cohort
por: Ren, Jingru, et al.
Publicado: (2022)

Integrated Analysis Reveals Altered Lipid and Glucose Metabolism and Identifies NOTCH2 as a Biomarker for Parkinson's Disease Related Depression
por: Dong, Mei-Xue, et al.
Publicado: (2018)

Non-Motor Symptoms of the Postural Instability and Gait Difficulty Subtype in De Novo Parkinson’s Disease Patients: A Cross-Sectional Study in a Single Center
por: Ren, Jingru, et al.
Publicado: (2020)

Abnormal cortical atrophy and functional connectivity are associated with depression in Parkinson’s disease
por: Yin, Weifang, et al.
Publicado: (2022)

Oral Mucosa Derived α−Synuclein as a Potential Diagnostic Biomarker for Parkinson′s Disease
por: Zheng, Yuanchu, et al.
Publicado: (2022)

Application of Neurotoxin-Induced Animal Models in the Study of Parkinson’s Disease-Related Depression: Profile and Proposal
por: Mou, Ya-Kui, et al.
Publicado: (2022)

Sex Differences in Brain and Cognition in de novo Parkinson's Disease
por: Oltra, Javier, et al.
Publicado: (2022)

Alterations of structure and functional connectivity of visual brain network in patients with freezing of gait in Parkinson’s disease
por: Gan, Lu, et al.
Publicado: (2022)

Levodopa Changes Functional Connectivity Patterns in Subregions of the Primary Motor Cortex in Patients With Parkinson’s Disease
por: Shen, Yang, et al.
Publicado: (2020)

Research on Xiaoyao Powder in the treatment of depression based on epigenetics and quality markers
por: Wang, Jiayun, et al.
Publicado: (2023)

Prefrontal Physiomarkers of Anxiety and Depression in Parkinson’s Disease
por: de Hemptinne, Coralie, et al.
Publicado: (2021)

Alterations of Erythrocytic Phosphorylated Alpha-Synuclein in Different Subtypes and Stages of Parkinson's Disease
por: Li, Xu-Ying, et al.
Publicado: (2021)

Altered Functional Connectivity Density in Subtypes of Parkinson’s Disease
por: Hu, Xiaofei, et al.
Publicado: (2017)

MicroRNA-4639 Is a Regulator of DJ-1 Expression and a Potential Early Diagnostic Marker for Parkinson’s Disease
por: Chen, Yimeng, et al.
Publicado: (2017)

Networks Are Associated With Depression in Patients With Parkinson’s Disease: A Resting-State Imaging Study
por: Liao, Haiyan, et al.
Publicado: (2021)

Association of Plasma and Electroencephalography Markers With Motor Subtypes of Parkinson’s Disease
por: Yang, Xiaoxia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pahf74tmtmb92j279mbjud9b6f